Antivirals interacting with hepatitis B virus core protein and core mutations may misdirect capsid assembly in a similar fashion
- 2 October 2003
- journal article
- review article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 66 (12) , 2273-2279
- https://doi.org/10.1016/j.bcp.2003.08.001
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Inhibition of Hepatitis B Virus Replication by Drug-Induced Depletion of NucleocapsidsScience, 2003
- Structure-Activity Relationship of a New Class of Anti-Hepatitis B Virus AgentsAntimicrobial Agents and Chemotherapy, 2002
- Biogenesis of p53 Involves Cotranslational Dimerization of Monomers and Posttranslational Dimerization of DimersJournal of Biological Chemistry, 2002
- Nuclear Pore Complex Is Able to Transport Macromolecules with Diameters of ∼39 nmMolecular Biology of the Cell, 2002
- Cis -preferential recruitment of duck hepatitis B virus core protein to the RNA/polymerase preassembly complexHepatology, 2002
- Peptide aptamers targeting the hepatitis B virus core protein: a new class of molecules with antiviral activityOncogene, 2001
- Hepatitis B Virus BiologyMicrobiology and Molecular Biology Reviews, 2000
- Intracellular single-chain antibody against hepatitis B virus core protein inhibits the replication of hepatitis B virus in cultured cellsHepatology, 1999
- Novel molecular approaches toward therapy of chronic hepatitis BArchiv für die gesamte Virusforschung, 1997
- A eukaryotic cytosolic chaperonin is associated with a high molecular weight intermediate in the assembly of hepatitis B virus capsid, a multimeric particle.The Journal of cell biology, 1994